Intranasal immunization of mutant toxic shock syndrome toxin 1 elicits systemic and mucosal immune response against Staphylococcus aureus infection

FEMS Immunology and Medical Microbiology

Volumn 52, Issue 3, 2008, Pages 389-396

  Narita, Kouji ^a   Hu, Dong Liang ^a   Tsuji, Takao ^b   Nakane, Akio ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Intranasal immunization; Mutant toxic shock syndrome toxin 1; Nasal colonization; Staphylococcus aureus

Indexed keywords

ANTIBODY; TOXIC SHOCK SYNDROME TOXIN 1;

ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NEUTROPHIL; NONHUMAN; NOSE CAVITY; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL TOXINS; ENTEROTOXINS; IMMUNITY, MUCOSAL; IMMUNIZATION; MICE; MICE, INBRED BALB C; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS; VACCINES, SYNTHETIC;

EID: 41049085755     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2008.00384.x     Document Type: Article

References (36)

1. Asanuma H, Thompson AH, Iwasaki T, Sato Y, Inaba Y, Aizawa C, Kurata T Tamura S (1997) Isolation and characterization of mouse nasal-associated lymphoid tissue. J Immunol Methods 202 : 123 131.
2. Bonventre PF, Heeg H, Cullen C Lian CJ (1993) Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome. Infect Immun 61 : 793 799.
3. Bonventre PF, Heeg H, Edwards CK III. Cullen CM (1995) A mutation at histidine residue 135 of toxic shock syndrome toxin yields an immunogenic protein with minimal toxicity. Infect Immun 63 : 509 515.
4. Cole AM, Tahk S, Oren A, Yoshioka D, Kim YH, Park A Ganz T (2001) Determinants of Staphylococcus aureus nasal carriage. Clin Diagn Lab Immunol 8 : 1064 1069.
5. Cullen CM, Blanco LR, Bonventre PF Choi E (1995) A toxic shock syndrome toxin 1 mutant that defines a functional site critical for T-cell activation. Infect Immun 63 : 2141 2146.
6. Drynda A, Konig B, Bonventre PF Konig W (1995) Role of a carboxy-terminal site of toxic shock syndrome toxin 1 in eliciting immune responses of human peripheral blood mononuclear cells. Infect Immun 63 : 1095 1101.
7. Ellis TN Beaman BL (2004) Interferon-gamma activation of polymorphonuclear neutrophil function. Immunology 112 : 2 12.
8. Gamble JR, Harlan JM, Klebanoff SJ Vadas MA (1985) Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc Natl Acad Sci USA 82 : 8667 8671.
9. Gampfer JM, Samstag A, Waclavicek M, Wolf HM, Eibl MM Gulle H (2002) Epitope mapping of neutralizing TSST-1 specific antibodies induced by immunization with toxin or toxoids. Vaccine 20 : 3675 3684.
10. Hu DL, Omoe K, Sasaki S, Sashinami H, Sakuraba H, Yokomizo Y, Shinagawa K Nakane A (2003) Vaccination with nontoxic mutant toxic shock syndrome toxin 1 protects against Staphylococcus aureus infection. J Infect Dis 188 : 743 752.
11. Hu DL, Omoe K, Narita K, Cui JC, Shinagawa K Nakane A (2006) Intranasal vaccination with a double mutant of staphylococcal enterotoxin C provides protection against Staphylococcus aureus infection. Microbes Infect 8 : 2841 2848.
12. Kiser KB, Cantey-Kiser JM Lee JC (1999) Development and characterization of a Staphylococcus aureus nasal colonization model in mice. Infect Immun 67 : 5001 5006.
13. Klebanoff SJ, Vadas MA, Harlan JM, Sparks LH, Gamble JR, Agosti JM Waltersdorph AM (1986) Stimulation of neutrophils by tumor necrosis factor. J Immunol 136 : 4220 4225.
14. Kluytmans J, van Belkum A Verbrugh H (1997) Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 10 : 505 520.
15. Kuklin NA, Clark DJ, Secore S et al 2006) A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model. Infect Immun 74 : 2215 2223.
16. Lycke N (2004) From toxin to adjuvant: the rational design of a vaccine adjuvant vector, CTA1-DD/ISCOM. Cell Microbiol 6 : 23 32.
17. Ma XX, Ito T, Chongtrakool P Hiramatsu K (2006) Predominance of clones carrying Panton-Valentine leukocidin genes among methicillin-resistant Staphylococcus aureus strains isolated in Japanese hospitals from 1979 to 1985. J Clin Microbiol 44 : 4515 4527.
18. Nakane A, Okamoto M, Asano M, Kohanawa M Minagawa T (1995) Endogenous gamma interferon, tumor necrosis factor, and interleukin-6 in Staphylococcus aureus infection in mice. Infect Immun 63 : 1165 1172.
19. Nakane A, Nishikawa S, Sasaki S, Miura T, Asano M, Kohanawa M, Ishiwata K Minagawa T (1996) Endogenous interleukin-4, but not interleukin-10, is involved in suppression of host resistance against Listeria monocytogenes infection in interferon-depleted mice. Infect Immun 64 : 1252 1258.
20. Nathan CF (1987) Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. J Clin Invest 80 : 1550 1560.
21. Nilsson IM, Verdrengh M, Ulrich RG, Bavari S Tarkowski A (1999) Protection against Staphylococcus aureus sepsis by vaccination with recombinant staphylococcal enterotoxin A devoid of superantigenicity. J Infect Dis 180 : 1370 1373.
22. O'Brien GJ, Riddell G, Elborn JS, Ennis M Skibinski G (2006) Staphylococcus aureus enterotoxins induce IL-8 secretion by human nasal epithelial cells. Respir Res 7 : 115.
23. Peterson ML, Ault K, Kremer MJ, Klingelhutz AJ, Davis CC, Squier CA Schlievert PM (2005) The innate immune system is activated by stimulation of vaginal epithelial cells with Staphylococcus aureus and toxic shock syndrome toxin 1. Infect Immun 73 : 2164 2174.
24. Piao C, Karasawa T, Totsuka K, Uchiyama T Kikuchi K (2005) Prospective surveillance of community-onset and healthcare-associated methicillin-resistant Staphylococcus aureus isolated from a university-affiliated hospital in Japan. Microbiol Immunol 49 : 959 970.
25. Rasheed JK, Arko RJ, Feeley JC, Chandler FW, Thornsberry C, Gibson RJ, Cohen ML, Jeffries CD Broome CV (1985) Acquired ability of Staphylococcus aureus to produce toxic shock-associated protein and resulting illness in a rabbit model. Infect Immun 47 : 598 604.
26. Rich J Lee JC (2005) The pathogenesis of Staphylococcus aureus infection in the diabetic NOD mouse. Diabetes 54 : 2904 2910.
27. Schaffer AC, Solinga RM, Cocchiaro J et al 2006) Immunization with Staphylococcus aureus clumping factor B, a major determinant in nasal carriage, reduces nasal colonization in a murine model. Infect Immun 74 : 2145 2153.
28. Shalaby MR, Aggarwal BB, Rinderknecht E, Svedersky LP, Finkle BS Palladino MA Jr. (1985) Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. J Immunol 135 : 2069 2073.
29. Stiles BG, Krakauer T Bonventre PF (1995) Biological activity of toxic shock syndrome toxin 1 and a site-directed mutant, H135A, in a lipopolysaccharide-potentiated mouse lethality model. Infect Immun 63 : 1229 1234.
30. van den Akker EL, Nouwen JL, Melles DC et al 2006) Staphylococcus aureus nasal carriage is associated with glucocorticoid receptor gene polymorphisms. J Infect Dis 194 : 814 818.
31. Verdrengh M Tarkowski A (1997) Role of neutrophils in experimental septicemia and septic arthritis induced by Staphylococcus aureus. Infect Immun 65 : 2517 2521.
32. von Eiff C, Becker K, Machka K, Stammer H Peters G (2001) Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med 344 : 11 16.
33. Wertheim HF, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA Nouwen JL (2005) The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 5 : 751 762.
34. Yamamoto S, Kiyono H, Yamamoto M, Imaoka K, Fujihashi K, Van Ginkel FW, Noda M, Takeda Y McGhee JR (1997) A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity. Proc Natl Acad Sci USA 94 : 5267 5272.
35. Zaraket H, Otsuka T, Saito K et al 2007) Molecular characterization of methicillin-resistant Staphylococcus aureus in hospitals in Niigata, Japan: divergence and transmission. Microbiol Immunol 51 : 171 176.
36. Zhu D, Barniak V, Zhang Y, Green B Zlotnick G (2006) Intranasal immunization of mice with recombinant lipidated P2086 protein reduces nasal colonization of group B Neisseria meningitidis. Vaccine 24 : 5420 5425.